{"name":"LISCure Biosciences","slug":"liscure-biosciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxQalllVUpOLXlHektrRVV6Q1R1VlBNaGlrc3VHSlRjcF91UkgyOHFmZGNMX0dvM1JhUkR1a0hTODVfNm13cUZtZjNBT1BJY191dzRCVmRKMjJzWTBjU2dOczhRM0lnalFhSndYWlV1V2lVQS05X2tLVVRvMWNkYkZvMGs2eERDa0dVV08xeUZfWUFYTXF1QnQ5Vl84SjE2WUpjUmtJU1ItZmFuTFg0UnhqZXpRbTA0QXFYcHctYmRZOXdKVkRZX1FJY2ZNcm8waFNHV1N4MGtsNjlXQkVTeW1pRDdhTklmUFlnemFtSjV6M3ZPSkc3aDdrb2Y0T3gzVHNJMXVLU3o1eDk4eTd3cUhlUmx2Y2pZMjVYUkFNci1EU2JJQm5Jd3Y3cUxFWVpMXzJHY1VvTXNCclVZZw?oc=5","date":"2026-02-05","type":"regulatory","source":"PR Newswire","summary":"Primary Sclerosing Cholangitis Market Outlook Highlights Rising Demand and Expanding Treatment Landscape Throughout the Forecast Period (2025-2034) | DelveInsight - PR Newswire","headline":"Primary Sclerosing Cholangitis Market Outlook Highlights Rising Demand and Expanding Treatment Landscape Throughout the ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxPZDlDd1FLbVFGWjhCTWxULVVTSmZQcVhhY1F2ejA3a1lybGVtYlpxYXRYQ0JYN1h5N2hybzltX0pzMWkyNE9ocXU3bV82ZVZFajVndm9qM1lyS0pxY25JOGZaSHZZMzJzbW53X09xcjRIeEFPMTNUaEFPQ2Z1cEh1WGh6UmczNlBlMEh1OG11bjVpbGtEaWJzRFRjYTJVbE42ZzB5akdJOXp3TG41eTNrOEloN1h5MFFnUjRIdEdQODBScjBSNUdtWkt5dllyVHQ1RkwySzA5NzN5VGxIRzVwSjR1SnptTWctV2FyNWFxV1pSc091TVBnOGJ3Mk9oWVNh?oc=5","date":"2025-11-13","type":"deal","source":"PR Newswire","summary":"LISCure Expands Global Partnerships for BBB Shuttle Platform 'ExoPN-101'; Signs Fourth MTA with Leading Pharma Partner - PR Newswire","headline":"LISCure Expands Global Partnerships for BBB Shuttle Platform 'ExoPN-101'; Signs Fourth MTA with Leading Pharma Partner","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNekNXaGhiTURXcFlXUFVGbGxxdmEwZWdIa1JUTmdkdC0wU20wWXE1bERBdHdKc3FEbGZ0Y0xvQUlhc2dET0NGNWpJQy1ocjNaNlpHUkVNZGRNcXg3UW5IM0xxdUt1cV9FdHFscWxCYTc3d1JxT3R5M3h4S2UwSTRfcnY3al9la3hhZjFvNms2d1VpWjZHVmgtM1lxR0JNazhqOWxyM1VZa1c3a3J5UWp5RWZmRTRqelRtVnlhaVpkY1F6MnNlVTloVDdlTVhXczRLalZzX0E2S1gyVDBlSGVTX2pXLU5naEE4?oc=5","date":"2025-11-10","type":"trial","source":"PR Newswire","summary":"LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis (PSC) - PR Newswire","headline":"LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis (PSC)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9DVHo5ZzdnTkV5S3RmVlFhQVJ4Z21HOGdOb0tOTUxIbHJ6UGcxV1ZpU2t1SFA2OTd4Vjlia3ZQcnRkWklYVXFRTzMxTVRBUFBTRUpQNTZMRDlCZUQxZ1NOVGtNaUJFcUZYdjhhWk530gFyQVVfeXFMTjl4dUF3MjJqV0gxNVdCXzVnT3pmajUtNEZBLWVwMlh5akdzcWY0d1JWbmZ5ZVV5T1Bpb2lTazBkcHRQOWdZU0VYZnVKaDFIWVlieGNhTnZyQ3QwMlZ6UXVCcGVnSTgwUEcydWE4THM2elBn?oc=5","date":"2023-04-05","type":"pipeline","source":"koreabiomed.com","summary":"Korea's microbiome industry shows robust growth despite late start, experts say - koreabiomed.com","headline":"Korea's microbiome industry shows robust growth despite late start, experts say","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFAxOGhLNy13RXU4TVVtT1VBMWpqRm44MU02TkVyNG1pRWJ4SUFhNjRiQW1JQWczdVo4WlJrLUlpVEUya2lEcFU0ME9FWWowSFlPSmN2N2Z1RTQzaDZkNW9jZVJJWXRfZmJidDlBMmV30gFyQVVfeXFMUHBDbFJjNV82cmpGOEd1NTVtaENYc0M2VWlaZ3VKZkhyYXpCa2YwNHRGUG9GRUllWlJpSnVfOVlQQzhVRko3SXlCNjZXeGIxa2s4T2Fma0l0M0xSbjJhZWN6clNnbm5tb1VSTkVGZ0t6cmZR?oc=5","date":"2023-02-23","type":"regulatory","source":"koreabiomed.com","summary":"NKMAX's NK cell therapy for Parkinson’s scores FDA compassionate use approval - koreabiomed.com","headline":"NKMAX's NK cell therapy for Parkinson’s scores FDA compassionate use approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOQmpwTEN6OUQ0Tzk2REJiVzR4eFhwcWQ4anRmbDlJNnFtc2E4NEVnZzJ1T1kxeS03bElld2R2X2toeUJHVEJjSGdxWWphN0tVekpDU1BWekpPODRSTXNyQmpsS1gyTHJDaVhXelg2aDI4QWJodmtpS2p0ZE9sa3NIRzFRZ2g2N052M3UwbHlzX1lUX1AyRi1LQkx2VWh5TS1EekVtRlpDZkVnT09RaFNMWjBScFdWTkFkLUdLOGpDRHRCUU54?oc=5","date":"2021-02-26","type":"pipeline","source":"PR Newswire","summary":"LISCure Biosciences Successfully Raises $21 million in Series B Funding - PR Newswire","headline":"LISCure Biosciences Successfully Raises $21 million in Series B Funding","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}